Benzyl benzoate has low to moderate toxicity depending on how you’re exposed to it. Applied to the skin as directed, which is its most common use for treating scabies and lice, it rarely causes anything worse than temporary stinging or burning. Swallowed in large quantities, it becomes dangerous, potentially causing tremors, convulsions, and respiratory failure. The distinction between safe topical use and hazardous ingestion is the key to understanding this compound.
How Your Body Processes Benzyl Benzoate
Your liver breaks down benzyl benzoate quickly. It splits the molecule into two parts: benzoic acid and benzyl alcohol. The benzyl alcohol is then further converted into more benzoic acid, which combines with an amino acid called glycine to form hippuric acid. Hippuric acid is water-soluble and leaves your body through urine. This rapid breakdown is the main reason topical application at recommended concentrations stays safe for most people.
Toxicity From Ingestion
Swallowing benzyl benzoate is a different story. The U.S. Environmental Protection Agency classifies it as moderately toxic by the oral route. In animal testing, the lethal dose for 50% of test subjects ranged from about 1.7 grams per kilogram of body weight in rabbits to 2.8 grams per kilogram in rats. Dogs tolerate it far better, with lethal doses exceeding 22 grams per kilogram.
Signs of poisoning from ingestion progress in severity: excessive salivation comes first, followed by muscle twitching, generalized tremors, convulsions, and in extreme cases, respiratory failure and death. These are central nervous system effects, meaning the compound overwhelms the brain’s ability to regulate muscle control and breathing when it enters the bloodstream in large amounts.
Through the skin, toxicity is much lower. The dermal lethal dose in rabbits exceeds 5,000 milligrams per kilogram, nearly three times higher than the oral lethal dose. Intact skin acts as an effective barrier, limiting how much reaches the bloodstream.
Side Effects From Topical Use
When applied to the skin for scabies treatment, benzyl benzoate is well tolerated by most people. In a randomized study comparing it to oral ivermectin, about 14% of patients using benzyl benzoate reported mild adverse effects. These were limited to short burning or stinging sensations at the application site, particularly on broken skin or areas where scratching had exposed mucous membranes like genital tissue. Other reported side effects include itching, pustules, skin irritation, and eczema.
The standard formulation is 25% for adults and 10 to 12.5% for children. Treatment typically involves applying the lotion for two to three consecutive days, then repeating after one week. Neurological complications are listed as a possible side effect but are rare at these concentrations and application schedules.
Risks for Infants and Pregnant Women
Benzyl benzoate carries specific concerns for newborns. Its metabolite, benzyl alcohol, has been linked to a condition called “gasping syndrome” in neonates, which involves a cascade of serious problems: brain damage, a dangerous shift in blood acidity, bone marrow suppression, and multiple organ failure. This association led to benzyl benzoate being banned as a drug product in the United States, though it remains widely used elsewhere in the world.
Current guidelines recommend against using benzyl benzoate on infants younger than two months. For pregnant women, it carries a Category C classification, meaning animal studies haven’t fully ruled out risk but no clear harm has been shown. A study of 444 pregnant women in Thailand who used 25% benzyl benzoate topically during their second and third trimesters found no increased risk of birth defects. Outside of local skin irritation, no reports of toxicity in animals or humans have surfaced from topical use during pregnancy. It is not recommended during breastfeeding because safety data for nursing infants is lacking.
Contact Allergy Risk
Benzyl benzoate is a recognized contact allergen. The European Union’s Scientific Committee on Consumer Safety lists it among established allergens in humans, with a moderate number of documented sensitization cases (between 100 and 1,000 reported). It appears in many fragranced products, including perfumes, lotions, and household items, and EU regulations require it to be listed on ingredient labels when present above certain thresholds.
For most people, this sensitization risk is low. But if you’ve noticed skin reactions to fragranced products in the past, benzyl benzoate could be one of the culprits worth checking ingredient lists for. A patch test through a dermatologist can confirm whether you’re sensitized to it.
The Bottom Line on Toxicity
Benzyl benzoate sits in a middle ground: not harmless, but not highly dangerous when used as intended. Your skin limits absorption enough that topical use at standard concentrations causes only mild, temporary irritation in a small percentage of users. Ingestion poses genuine danger, particularly in large amounts, with neurotoxic effects that can escalate to life-threatening levels. The most vulnerable populations are newborns, whose immature livers cannot efficiently clear the metabolite benzyl alcohol, and individuals with existing skin damage, who absorb more of the compound through broken barriers.